330 related articles for article (PubMed ID: 29212434)
1. Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.
Younis IR; Ahmed MA; Burman KD; Soldin OP; Jonklaas J
Thyroid; 2018 Jan; 28(1):41-49. PubMed ID: 29212434
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and pharmacokinetics of levothyroxine suppository in patients with hypothyroidism.
Kashiwagura Y; Uchida S; Tanaka S; Watanabe H; Masuzawa M; Sasaki T; Namiki N
Biol Pharm Bull; 2014; 37(4):666-70. PubMed ID: 24694613
[TBL] [Abstract][Full Text] [Related]
3. Analysis of dose-TSH response effect of levothyroxine soft-gel formulation.
Trimboli P; Piticchio T; Dadda Z; Stramazzo I; Gamarra E; Ruinelli L; Virili C
Front Endocrinol (Lausanne); 2024; 15():1340204. PubMed ID: 38449850
[TBL] [Abstract][Full Text] [Related]
4. Improved levothyroxine pharmacokinetics after bariatric surgery.
Gkotsina M; Michalaki M; Mamali I; Markantes G; Sakellaropoulos GC; Kalfarentzos F; Vagenakis AG; Markou KB
Thyroid; 2013 Apr; 23(4):414-9. PubMed ID: 23110329
[TBL] [Abstract][Full Text] [Related]
5. The Levothyroxine Absorption Test: A Four-Year Experience (2015-2018) at The Mayo Clinic.
Gonzales KM; Stan MN; Morris JC; Bernet V; Castro MR
Thyroid; 2019 Dec; 29(12):1734-1742. PubMed ID: 31680654
[No Abstract] [Full Text] [Related]
6. Levothyroxine Therapy in Thyrodectomized Patients.
Miccoli P; Materazzi G; Rossi L
Front Endocrinol (Lausanne); 2020; 11():626268. PubMed ID: 33584551
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal comparison of thyroxine pharmacokinetics between pregnant and nonpregnant women: a stable isotope study.
Soldin OP; Soldin SJ; Vinks AA; Younis I; Landy HJ
Ther Drug Monit; 2010 Dec; 32(6):767-73. PubMed ID: 20962709
[TBL] [Abstract][Full Text] [Related]
9. Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study.
Skelin M; Lucijanić T; Liberati-Čizmek AM; Klobučar SM; Lucijanić M; Jakupović L; Bakula M; Lončar JV; Marušić S; Matić T; Romić Ž; Dumić J; Rahelić D
Endocrine; 2018 Nov; 62(2):432-439. PubMed ID: 30043093
[TBL] [Abstract][Full Text] [Related]
10. A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal.
Ducharme M; Scarsi C; Bettazzi E; Mautone G; Lewis Y; Celi FS
Thyroid; 2022 Aug; 32(8):897-904. PubMed ID: 35469428
[No Abstract] [Full Text] [Related]
11. LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.
Glymph K; Gosmanov AR
Endocr Pract; 2016 Jan; 22(1):22-9. PubMed ID: 26437220
[TBL] [Abstract][Full Text] [Related]
12. The influence of age and body weight on levothyroxine replacement dosage to achieve euthyroidism in patients with primary hypothyroidism.
Pustilnik E; Schwarzstein D; Feldman R; Mancinelli L; Paladini L; Pellizzón NA; Ramírez Stieben LA
Endocrinol Diabetes Nutr (Engl Ed); 2021 Oct; 68(8):542-547. PubMed ID: 34872637
[TBL] [Abstract][Full Text] [Related]
13. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.
Van Tassell B; Wohlford GF; Linderman JD; Smith S; Yavuz S; Pucino F; Celi FS
Thyroid; 2019 Oct; 29(10):1371-1379. PubMed ID: 31364488
[No Abstract] [Full Text] [Related]
15. A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease.
Di Donna V; Santoro MG; de Waure C; Ricciato MP; Paragliola RM; Pontecorvi A; Corsello SM
Thyroid; 2014 Dec; 24(12):1759-64. PubMed ID: 25268754
[TBL] [Abstract][Full Text] [Related]
16. Levothyroxine dose following thyroidectomy is affected by more than just body weight.
Baehr KM; Lyden E; Treude K; Erickson J; Goldner W
Laryngoscope; 2012 Apr; 122(4):834-8. PubMed ID: 22374624
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of coadministration of levothyroxine sodium and alendronate sodium new effervescent formulation.
Bone HG; Walter MA; Hurley ME; Epstein S
Osteoporos Int; 2017 May; 28(5):1745-1752. PubMed ID: 28204953
[TBL] [Abstract][Full Text] [Related]
18. Profile of Levothyroxine Replacement Therapy in Graves' Disease Patients with Hypothyroidism Post-Radioactive Iodine Ablation: Focus on Different Weight-Based Regimens.
Mathiphanit S; Yenseung N; Chatchomchuan W; Butadej S; Nakasatien S; Wanothayaroj E; Rajatanavin R; Himathongkam T; Thewjitcharoen Y
J ASEAN Fed Endocr Soc; 2022; 37(1):62-68. PubMed ID: 35800593
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic properties of mirabegron, a β3-adrenoceptor agonist: results from two phase I, randomized, multiple-dose studies in healthy young and elderly men and women.
Krauwinkel W; van Dijk J; Schaddelee M; Eltink C; Meijer J; Strabach G; van Marle S; Kerbusch V; van Gelderen M
Clin Ther; 2012 Oct; 34(10):2144-60. PubMed ID: 23063375
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
